In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In other words, the price has increased by $0.00 from its previous closing price. On the day, 4.41 million shares were traded. TNYA stock price reached its highest trading level at $2.945 during the session, while it also had its lowest trading level at $2.56.
Ratios:
For a deeper understanding of Tenaya Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.27 and its Current Ratio is at 5.27. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.10.
On November 30, 2023, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.H.C. Wainwright initiated its Buy rating on June 15, 2022, with a $25 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 18 ’24 when Saito Chihiro sold 2,258 shares for $2.12 per share. The transaction valued at 4,787 led to the insider holds 60,983 shares of the business.
Saito Chihiro sold 2,363 shares of TNYA for $6,840 on Aug 16 ’24. The SVP, Accounting and Fin. Ops. now owns 63,241 shares after completing the transaction at $2.89 per share. On Aug 16 ’24, another insider, Tingley Whittemore, who serves as the Chief Medical Officer of the company, sold 7,428 shares for $2.89 each. As a result, the insider received 21,500 and left with 107,106 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 217856368 and an Enterprise Value of 152925424.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $7.01, while it has fallen to a 52-week low of $1.61. The 50-Day Moving Average of the stock is 14.51%, while the 200-Day Moving Average is calculated to be -18.63%.
Shares Statistics:
For the past three months, TNYA has traded an average of 3.11M shares per day and 4439980 over the past ten days. A total of 79.22M shares are outstanding, with a floating share count of 65.64M. Insiders hold about 17.15% of the company’s shares, while institutions hold 57.30% stake in the company. Shares short for TNYA as of 1732838400 were 14048506 with a Short Ratio of 4.51, compared to 1730332800 on 5244350. Therefore, it implies a Short% of Shares Outstanding of 14048506 and a Short% of Float of 25.39.
